This week, South Africa announced it would halt the rollout of 1 million doses of the Oxford-AstraZeneca vaccine after results from a recent study showed the vaccine wasn’t effective against mild and moderate cases of a local COVID-19 variant. Now, the country is having to reevaluate its vaccine rollout strategy. The World’s Halima Gikandi reports.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?